Healthpeak Raises Full-Year Guidance, Reports Strong Q2 Results, and Authorizes New $500M Buyback

summarizeSummary

Healthpeak Properties reported solid Q2 results, raised its full-year earnings guidance, and authorized a new $500 million share repurchase program, following significant capital recycling activities.

check_boxKey Events · Earnings and Guidance · DOC

• Full-Year Guidance Increased

  Healthpeak raised its full-year 2026 guidance for diluted EPS, FFO as Adjusted per share, and Total Same-Store Cash (Adjusted) NOI Growth, indicating improved outlook.

• Strong Q2 Financial Performance

  Reported diluted net income of $0.08 per share (up from $0.05 YoY) and FFO as Adjusted of $0.46 per share (flat YoY), reflecting solid operational results.

• Significant Capital Recycling

  Generated $1.4 billion in proceeds, including $1.025 billion from the sale of a 49% joint venture interest in an outpatient medical portfolio to Brookfield, used to repay $650 million in senior notes and $375 million in commercial paper.

• New Share Repurchase Program

  The Board of Directors authorized a new $500 million share repurchase program, replacing the existing authorization, demonstrating confidence in the company's valuation.

auto_awesomeAnalysis · DOC · Real Estate & Construction

Healthpeak Properties delivered a strong second quarter, leading to an increase in its full-year 2026 earnings guidance. The company successfully executed its capital allocation strategy by generating $1.4 billion in proceeds, notably from a $1.025 billion joint venture with Brookfield, which significantly strengthened its balance sheet through debt repayments. The authorization of a new $500 million share repurchase program further signals management's confidence and commitment to shareholder returns. These positive operational and financial developments are likely to be viewed favorably by investors.